Compile Data Set for Download or QSAR

Found 24 hits of Enzyme Inhibition Constant Data   

TargetMacrophage colony-stimulating factor 1 receptor(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of CSF1R (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of p38alpha (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetPlatelet-derived growth factor receptor beta(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 31nMAssay Description:Inhibition of PDGFRb (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256724(CHEMBL475794 | N-(5-chloropyridin-3-yl)-5-(3-(2-cy...)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetFocal adhesion kinase 1(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 478nMAssay Description:Inhibition of PTK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetEphrin type-B receptor 4(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 672nMAssay Description:Inhibition of EphB4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 700nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256751(CHEMBL514670 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256679(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methyl-N-(5-...)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256727(CHEMBL475799 | N-(6-amino-5-chloropyridin-3-yl)-5-...)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256636(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methyl-N-(6-...)copy SMILEScopy InChI
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256634(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methyl-N-(6-...)copy SMILEScopy InChI
Affinity DataIC50: 9.80E+3nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetFibroblast growth factor receptor 1(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+4nMAssay Description:Inhibition of Jak2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetInsulin-like growth factor 1 receptor(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of IGFR1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetMitogen-activated protein kinase 8(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Jnk1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetSerine/threonine-protein kinase PLK1(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Plk (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Src (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Kdr (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Cdk2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of EGFR (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetSerine/threonine-protein kinase PAK 1(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Pak1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetTyrosine-protein kinase CSK(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Csk (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
TargetSerine/threonine-protein kinase Chk1(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50256750(CHEMBL475817 | N-(6-amino-5-chloropyridin-3-yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of Chk1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2222TMPPubMed
* indicates data uncertainty>20%